Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochemical Pharmacology

• Publication date

  2014-11-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2014.08.025PMID 25181459PMCID PMC4252478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2.

  2014cited by this paper
• Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.

  2014cited by this paper
• Modulation of Xenobiotic Receptors by Steroids

  2013cited by this paper
• Differential regulation of CYP3A4 promoter activity by a new class of natural product derivatives binding to pregnane X receptor.

  2013influential reference
• Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1.

  2013cited by this paper
• Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors.

  2013cited by this paper
• The Role of Outpatient Intravenous Diuretic Therapy in a Transitional Care Program for Patients With Heart Failure: A Case Series

  2012cited by this paper
• Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.

  2012cited by this paper
• Interactions Between Herbal Medicines and Prescribed Drugs

  2012cited by this paper
• Interactions Between Herbal Medicines and Prescribed Drugs

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Nuclear receptor PXR, transcriptional circuits and metabolic relevance.

  2011cited by this paper
• In Vivo and In Vitro Characterization of a First-in-Class Novel Azole Analog That Targets Pregnane X Receptor Activation

  2011cited by this paper
• Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs via Ligand-Based Virtual Screening

  2011cited by this paper
• Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR.

  2011cited by this paper
• Protein Phosphatase 2Cβl Regulates Human Pregnane X Receptor-Mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells

  2010cited by this paper
• Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging pollutants: screening of chemicals and application to water samples

  2010cited by this paper
• Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines

  2009cited by this paper
• Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries

  2009cited by this paper
• A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor

  2009cited by this paper
• Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.

  2009cited by this paper
• Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.

  2008cited by this paper
• Machine learning methods and docking for predicting human pregnane X receptor activation.

  2008cited by this paper
• Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells*

  2008influential reference
• Nuclear receptor drug discovery.

  2008cited by this paper
• Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition.

  2007cited by this paper
• Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions.

  2006cited by this paper
• Overview of Nomenclature of Nuclear Receptors

  2006cited by this paper
• Beneficial Effects of Metolazone in a Rat Model of Preeclampsia

  2006cited by this paper
• Pregnane X receptor and natural products: beyond drug–drug interactions

  2006cited by this paper
• The nuclear receptor superfamily: a rosetta stone for physiology.

  2005cited by this paper
• Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents

  2005cited by this paper
• Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.

  2005cited by this paper
• Induction of CYP3A4 by Efavirenz in Primary Human Hepatocytes: Comparison With Rifampin and Phenobarbital

  2004cited by this paper
• Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism.

  2004cited by this paper
• Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor.

  2003cited by this paper
• 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.

  2003cited by this paper
• Drug-drug interactions among elderly patients hospitalized for drug toxicity.

  2003cited by this paper
• Pxr, car and drug metabolism

  2002cited by this paper
• Structural insights into the promiscuity and function of the human pregnane X receptor.

  2002cited by this paper
• A pharmacophore for human pregnane X receptor ligands.

  2002cited by this paper
• The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity

  2001influential reference
• Metolazone-induced cholestatic liver disease.

  2001cited by this paper
• St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

  2000cited by this paper
• THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS*

  2000cited by this paper
• Induction of Drug Metabolising Enzymes

  2000cited by this paper
• Cytochrome P-450 3A4: regulation and role in drug metabolism.

  1999cited by this paper
• Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

  1998cited by this paper
• Hepatic dysfunction associated with troglitazone.

  1998cited by this paper
• P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.

  1996cited by this paper
• Use of Metolazone in the Treatment of Ascites due to Liver Disease

  1971cited by this paper

• Skeletal Editing of Isatins for Heterocycle Molecular Diversity

  2024cites this paper
• Pharmacokinetic Drug-Drug Interactions: A Systematic Review of the Cytochrome P450 (CYP) Isoenzyme 3A4

  2023cites this paper
• Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning

  2021cites this paper
• Helix 12 stabilization contributes to basal transcriptional activity of PXR

  2021cites this paper
• Mutation of a single amino acid of pregnane X receptor switches an antagonist to agonist by altering AF-2 helix positioning

  2020cites this paper
• Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor.

  2019cites this paper
• Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells

  2016cites this paper
• Clinical Impacts of Cyp 3 a 4 Isoenzyme on Drugs Used in Treatment of Cardiovascular Diseases : Drug-Drug Interactions

  2016cites this paper
• The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors

  2016cites this paper
• Tryptophan 299 is a conserved residue of human pregnane X receptor critical for the functional consequence of ligand binding.

  2016influential citation
• Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assays

  2016cites this paper
• Targeting xenobiotic receptors PXR and CAR in human diseases.

  2015cites this paper